Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Public ClinicalTrials.gov record NCT02352779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized pilot clinical trial studies omega-3 fatty acid in reducing cancer-related fatigue in breast cancer survivors. Supplementation with omega-3 fatty acid may help reduce cancer-related fatigue in breast cancer survivors.
Study identification
- NCT ID
- NCT02352779
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 108 participants
Conditions and interventions
Conditions
Interventions
- Omega-3 Fatty Acid Dietary Supplement
- Placebo Other
- Questionnaire Administration Other
- Laboratory Biomarker Analysis Other
Dietary Supplement · Other
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2015
- Primary completion
- Jan 31, 2016
- Completion
- Mar 31, 2016
- Last update posted
- Aug 7, 2017
2015 – 2016
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Wichita NCORP | Wichita | Kansas | 67214 | — |
| Cancer Research Consortium of West Michigan | Grand Rapids | Michigan | 49503 | — |
| University of Rochester NCORP Research Base | Rochester | New York | 14642 | — |
| Dayton NCORP | Dayton | Ohio | 45420 | — |
| Greenville Health System NCORP | Greenville | South Carolina | 29605 | — |
| Wisconsin NCORP | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02352779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2017 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02352779 live on ClinicalTrials.gov.